Welcome to our dedicated page for iRhythm Holdings SEC filings (Ticker: IRTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
iRhythm Holdings, Inc. filings document the public-company reporting of a digital health care business centered on ambulatory cardiac monitoring. Recent Form 8-K disclosures report operating results, financial condition, guidance-related exhibits, Regulation FD materials, material agreements, executive compensation policy changes, board appointments, and changes in the independent registered public accounting firm.
Proxy materials cover director elections, board and committee structure, executive compensation, equity awards, and stockholder voting matters. The filing record also documents the completed holding-company reorganization under which iRhythm Holdings became successor registrant to iRhythm Technologies, including common-stock continuity and predecessor registration-termination records.
Wilson Daniel G. reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported an equity award of 8,361 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock. Following this grant, his directly held common stock position is 39,055 shares.
According to the terms, 25% of the RSUs vest on March 1, 2027, with an additional 25% vesting on each one-year anniversary thereafter, so long as he continues as a service provider through each vesting date. The filing also notes an additional 100 shares of common stock held indirectly through The Wilson Living Trust dated July 9, 2015, for which Mr. Wilson serves as Trustee.
Turakhia Minang reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. reported that executive Minang Turakhia received an equity award in the form of Restricted Stock Units (RSUs) covering 10,034 shares of common stock at no cash cost on the grant date. Each RSU represents a right to receive one share if vesting conditions are met.
According to the vesting schedule, 25% of these RSUs vest on March 1, 2027, with the remaining RSUs vesting in equal portions on each one-year anniversary thereafter, as long as Turakhia continues as a service provider through each vesting date. Following this grant, Turakhia directly holds 58,933 shares of common stock.
iRhythm Holdings, Inc. reported that President and CEO Quentin S. Blackford acquired 31,842 shares of common stock through a grant of Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of common stock if vesting conditions are met. Following this award, he directly holds 217,968 shares. According to the grant terms, 25% of the RSUs vest on March 1, 2027 and on each one-year anniversary after that date, as long as he continues as a service provider.
Patterson Chad reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. reported that Chief Commercial & Product Officer Chad Patterson received an equity award in the form of restricted stock units. He was granted 10,870 RSUs, each representing a contingent right to receive one share of iRhythm common stock at no cash cost.
According to the vesting schedule, 25% of the RSUs vest on March 1, 2027, with additional 25% portions vesting on each one-year anniversary thereafter, as long as he continues as a service provider through each vesting date. Following this grant, his reported direct ownership increased to 62,608 shares of common stock.
Rosenbaum Marc Wade reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. reported that Chief Accounting Officer Marc Wade Rosenbaum received a grant of 2,508 Restricted Stock Units (RSUs) of common stock on February 25, 2026. Each RSU represents one share, with 25% vesting on March 1, 2027 and on each following one-year anniversary, subject to continued service. Following this award, his directly held common stock position is 17,522 shares.
Murphy Patrick Michael reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings executive Patrick Michael Murphy, the company’s CBO and CLO, received an equity award covering 7,024 shares of common stock in the form of Restricted Stock Units (RSUs). Each RSU represents a right to receive one share of common stock at vesting.
According to the filing, 25% of the RSUs vest on March 1, 2027, with an additional 25% vesting on each one-year anniversary thereafter, as long as he continues as a service provider through each vesting date. Following this grant, he holds 67,560 shares of common stock directly.
Smith Mervin reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings EVP Strategic Business Ops Mervin Smith received an equity award of 6,689 restricted stock units of common stock. These RSUs were granted on February 25, 2026 at no cash cost. 25% of the units vest on March 1, 2027 and on each one-year anniversary after that, so long as he continues as a service provider. Following this award, he directly holds 26,964 shares of common stock.
iRhythm Holdings, Inc. executive Sean Clinton Freeman, EVP of Strategy & Corporate Development, reported an equity award on Form 4. He acquired 7,525 shares of common stock through a grant of Restricted Stock Units at a stated price of $0.00 per unit, bringing his directly held total to 14,286 shares after the grant. The RSUs vest over four years, with 25% vesting on March 1, 2027 and additional 25% installments on each one-year anniversary, so long as he continues as a service provider through each vesting date.
Shrishrimal Sumi reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. executive Sumi Shrishrimal, EVP and Chief Risk Officer, received a grant of 5,518 shares of Common Stock in the form of Restricted Stock Units (RSUs) on February 25, 2026 at a stated price of $0.00 per share. Following this equity award, her directly held common stock position is reported as 44,700 shares. Each RSU represents a right to receive one share of common stock, with 25% of the RSUs scheduled to vest on March 1, 2027 and the remaining RSUs vesting in equal installments on each one-year anniversary thereafter, contingent on her continued service.
Lawrence Brian Lee reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings Chief Technology Officer Lawrence Brian Lee reported receiving an equity award tied to the company’s common stock. He was granted 6,689 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock for no cash payment.
According to the award terms, 25% of the RSUs vest on March 1, 2027 and on each one-year anniversary thereafter, as long as he continues as a service provider through each vesting date. After this grant, Lee directly holds 21,168 shares of common stock, reflecting his increased equity-based stake in the company.